Acasti Pharma Investor Relations Material
Latest events
Q3 2023
Acasti Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Acasti Pharma Inc
Access all reports
Acasti Pharma Inc., is an Canadian biopharmaceutical company that engages in the development and commercialization of pharmaceutical products for the treatment of dyslipidemia and cardiometabolic risk factors. Its lead drug candidate, CaPre, is a prescription-only medication for the treatment of hypertriglyceridemia. It offers CoregCR, a registered therapeutic formulation of carvedilol for the treatment of hypertension and heart failure for patients with chronic renal impairment.
Latest articles
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
ACST
Country
đ¨đŚ Canada